UPDATE: Sequenom to Acquire Gemini Genomics in Deal Valued at $238M | GenomeWeb

This story has been updated from a previous version.

NEW YORK, May 29 - Sequenom has agreed to acquire Gemini Genomics in a stock-for-stock deal valued at $238 million, the companies said Tuesday.   

The merger will leverage Sequenom's capabilities in large-scale genetic analysis with Gemini's databases of clinical and phenotypical information, the companies said.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.